Fjarde Ap Fonden United Therapeutics Corp Call Options Transaction History
Fjarde Ap Fonden
- $9.04 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding UTHR
# of Institutions
643Shares Held
45.2MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$2.06 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.67 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.24 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.08 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$864 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $17.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...